Virtu Financial LLC Mirum Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
SELL
$27.14 - $34.93 $42,365 - $54,525
-1,561 Reduced 18.49%
6,881 $203,000
Q3 2023

Nov 14, 2023
SELL
$24.63 - $32.85 $169,577 - $226,172
-6,885 Reduced 44.92%
8,442 $267,000
Q2 2023

Jul 27, 2023
BUY
$23.51 - $30.09 $360,337 - $461,189
15,327 New
15,327 $397,000

Others Institutions Holding MIRM

# of Institutions
197
Shares Held
54.3M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.85B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email